• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

美国慢性肾脏病流行病学监测 - NHANES 和 KEEP 的联合分析。

Surveillance of CKD epidemiology in the US - a joint analysis of NHANES and KEEP.

机构信息

Internal Medicine, University of New Mexico, Albuquerque, NM, 87131, Mexico.

David Geffen School of Medicine, UCLA, Los Angeles, CA, 90024, USA.

出版信息

Sci Rep. 2018 Oct 26;8(1):15900. doi: 10.1038/s41598-018-34233-w.

DOI:10.1038/s41598-018-34233-w
PMID:30367154
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6203800/
Abstract

Chronic Kidney Disease (CKD), is highly prevalent in the United States. Epidemiological systems for surveillance of CKD rely on data that are based solely on the NHANES survey, which does not include many patients with the most severe and less frequent forms of CKD. We investigated the feasibility of estimating CKD prevalence from the large-scale community disease detection Kidney Early Evaluation and Program (KEEP, n = 127,149). We adopted methodologies from the field of web surveys to address the self-selection bias inherent in KEEP. Primary outcomes studied were CKD Stage 3-5 (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m, and CKD Stage 4-5 (eGFR <30 mL/min/1.73 m). The unweighted prevalence of Stage 4-5 CKD was higher in KEEP (1.00%, 95%CI: 0.94-1.05%) than in NHANES (0.51%, 95% CI: 0.43-0.59%). Application of a selection model that used  variables related to demographics, recruitment and socio-economic factors resulted in estimates similar to NHANES (0.55%, 95% CI: 0.50-0.60%). Weighted prevalence of Stages 3-5 CKD in KEEP was 6.45% (95% CI: 5.70-7.28%) compared to 6.73% (95% CI: 6.30-7.19%) for NHANES. Application of methodologies that address the self-selection bias in the KEEP program may allow the use of this large, geographically diverse dataset for CKD surveillance.

摘要

慢性肾脏病(CKD)在美国的发病率很高。CKD 的流行病学监测系统依赖于仅基于 NHANES 调查的数据,而该调查并未包括许多患有最严重和较少见的 CKD 形式的患者。我们研究了从大规模社区疾病检测 Kidney Early Evaluation and Program (KEEP,n=127149) 中估算 CKD 患病率的可行性。我们采用了网络调查领域的方法,以解决 KEEP 中固有的自我选择偏差。主要研究结果是 CKD 3-5 期(估计肾小球滤过率[eGFR]<60mL/min/1.73m,和 CKD 4-5 期(eGFR<30mL/min/1.73m)。KEEP 中未加权的 4-5 期 CKD 患病率高于 NHANES(1.00%,95%CI:0.94-1.05%)(0.51%,95%CI:0.43-0.59%)。应用一种选择模型,该模型使用与人口统计学、招募和社会经济因素相关的变量,得出的估计值与 NHANES 相似(0.55%,95%CI:0.50-0.60%)。KEEP 中 3-5 期 CKD 的加权患病率为 6.45%(95%CI:5.70-7.28%),而 NHANES 为 6.73%(95%CI:6.30-7.19%)。应用解决 KEEP 计划中自我选择偏差的方法可能允许使用这个大型、地理上多样化的数据集进行 CKD 监测。

相似文献

1
Surveillance of CKD epidemiology in the US - a joint analysis of NHANES and KEEP.美国慢性肾脏病流行病学监测 - NHANES 和 KEEP 的联合分析。
Sci Rep. 2018 Oct 26;8(1):15900. doi: 10.1038/s41598-018-34233-w.
2
Chronic kidney disease in US adults with type 2 diabetes: an updated national estimate of prevalence based on Kidney Disease: Improving Global Outcomes (KDIGO) staging.美国2型糖尿病成年患者的慢性肾脏病:基于改善全球肾脏病预后组织(KDIGO)分期的患病率最新全国估计数
BMC Res Notes. 2014 Jul 2;7:415. doi: 10.1186/1756-0500-7-415.
3
CKD and cardiovascular disease in screened high-risk volunteer and general populations: the Kidney Early Evaluation Program (KEEP) and National Health and Nutrition Examination Survey (NHANES) 1999-2004.筛查的高危志愿者和普通人群中的慢性肾脏病与心血管疾病:肾脏早期评估项目(KEEP)及1999 - 2004年国家健康与营养检查调查(NHANES)
Am J Kidney Dis. 2008 Apr;51(4 Suppl 2):S38-45. doi: 10.1053/j.ajkd.2007.12.017.
4
Association of apolipoprotein A1 and B with kidney function and chronic kidney disease in two multiethnic population samples.载脂蛋白 A1 和 B 与两个多民族人群样本肾功能和慢性肾脏病的关系。
Nephrol Dial Transplant. 2012 Jul;27(7):2839-47. doi: 10.1093/ndt/gfr795. Epub 2012 Jan 28.
5
Prevalence of anemia in chronic kidney disease in the United States.美国慢性肾脏病患者贫血的患病率
PLoS One. 2014 Jan 2;9(1):e84943. doi: 10.1371/journal.pone.0084943. eCollection 2014.
6
Hypertension in early-stage kidney disease: an update from the Kidney Early Evaluation Program (KEEP).早期肾病中的高血压:肾脏早期评估项目(KEEP)的最新进展
Am J Kidney Dis. 2009 Apr;53(4 Suppl 4):S22-31. doi: 10.1053/j.ajkd.2008.11.028.
7
Evaluation of cardiovascular disease burden and therapeutic goal attainment in US adults with chronic kidney disease: an analysis of national health and nutritional examination survey data, 2001-2010.评估美国慢性肾脏病成年患者的心血管疾病负担和治疗目标达标情况:基于 2001-2010 年全国健康和营养调查数据的分析。
BMC Nephrol. 2013 Jun 27;14:132. doi: 10.1186/1471-2369-14-132.
8
Association Between Obesity and Chronic Kidney Disease, Defined by Both Glomerular Filtration Rate and Albuminuria, in Korean Adults.韩国成年人中肥胖与由肾小球滤过率和蛋白尿定义的慢性肾脏病之间的关联
Metab Syndr Relat Disord. 2017 Oct;15(8):416-422. doi: 10.1089/met.2017.0053. Epub 2017 Aug 23.
9
Estimating prevalence of CKD stages 3-5 using health system data.利用卫生系统数据估计 3-5 期慢性肾脏病的患病率。
Am J Kidney Dis. 2013 Jun;61(6):930-8. doi: 10.1053/j.ajkd.2013.01.018. Epub 2013 Mar 13.
10
Prevalence of chronic kidney disease defined by using CKD-EPI equation and albumin-to-creatinine ratio in the Korean adult population.使用CKD-EPI方程和白蛋白与肌酐比值定义的慢性肾脏病在韩国成年人群中的患病率。
Korean J Intern Med. 2016 Nov;31(6):1120-1130. doi: 10.3904/kjim.2015.193. Epub 2016 Mar 25.

引用本文的文献

1
Comparative analysis of dietary pattern indices and their associations with chronic kidney disease: a comprehensive analysis of NHANES data (2000-2020).饮食模式指数及其与慢性肾脏病的关联的比较分析:对美国国家健康与营养检查调查(NHANES)数据(2000 - 2020年)的综合分析
Ren Fail. 2025 Dec;47(1):2540565. doi: 10.1080/0886022X.2025.2540565. Epub 2025 Aug 5.
2
Laboratory-based surveillance of chronic kidney disease in people with private health coverage in Brazil.巴西私人医疗保险覆盖人群中慢性肾脏病的基于实验室的监测。
BMC Nephrol. 2024 May 10;25(1):162. doi: 10.1186/s12882-024-03597-9.
3
Electronic Phenotype for Advanced Chronic Kidney Disease in a Veteran Health Care System Clinical Database: Systems-Based Strategy for Model Development and Evaluation.

本文引用的文献

1
Understanding CKD among patients with T2DM: prevalence, temporal trends, and treatment patterns-NHANES 2007-2012.了解 T2DM 患者中的 CKD:患病率、时间趋势和治疗模式-NHANES 2007-2012。
BMJ Open Diabetes Res Care. 2016 Apr 11;4(1):e000154. doi: 10.1136/bmjdrc-2015-000154. eCollection 2016.
2
Applying spatial analysis tools in public health: an example using SaTScan to detect geographic targets for colorectal cancer screening interventions.应用空间分析工具于公共卫生领域:以 SaTScan 检测结直肠癌筛查干预措施的地理目标为例。
Prev Chronic Dis. 2014 Mar 20;11:E41. doi: 10.5888/pcd11.130264.
3
Prevalence of anemia in chronic kidney disease in the United States.
退伍军人医疗系统临床数据库中晚期慢性肾病的电子表型:基于系统的模型开发与评估策略
Interact J Med Res. 2023 Jul 24;12:e43384. doi: 10.2196/43384.
4
Chronic kidney disease in primary care: risk of cardiovascular events, end stage kidney disease and death.基层医疗中的慢性肾脏病:心血管事件、终末期肾病和死亡风险。
BMC Prim Care. 2023 Jun 21;24(1):128. doi: 10.1186/s12875-023-02077-7.
5
Tailoring capture-recapture methods to estimate registry-based case counts based on error-prone diagnostic signals.根据易出错的诊断信号定制捕获-再捕获方法来估计基于登记的病例数。
Stat Med. 2023 Jul 30;42(17):2928-2943. doi: 10.1002/sim.9759. Epub 2023 May 9.
6
Incorporating Tryptase Genotyping Into the Workup and Diagnosis of Mast Cell Diseases and Reactions.将类胰蛋白酶基因分型纳入肥大细胞疾病和反应的研究和诊断。
J Allergy Clin Immunol Pract. 2022 Aug;10(8):1964-1973. doi: 10.1016/j.jaip.2022.05.003. Epub 2022 May 18.
7
Effects of Testing and Disclosing Ancestry-Specific Genetic Risk for Kidney Failure on Patients and Health Care Professionals: A Randomized Clinical Trial.检测和披露与肾功能衰竭相关的特定种族遗传风险对患者和医疗保健专业人员的影响:一项随机临床试验。
JAMA Netw Open. 2022 Mar 1;5(3):e221048. doi: 10.1001/jamanetworkopen.2022.1048.
8
Immunosuppression in Glomerular Diseases: Implications for SARS-CoV-2 Vaccines and COVID-19.肾小球疾病中的免疫抑制:对严重急性呼吸综合征冠状病毒2疫苗和冠状病毒病的影响
Glomerular Dis. 2021 Aug 25;1(4):277-293. doi: 10.1159/000519182. eCollection 2021 Oct.
9
Accuracy of identifying diagnosis of moderate to severe chronic kidney disease in administrative claims data.在行政索赔数据中识别中度至重度慢性肾脏病诊断的准确性。
Pharmacoepidemiol Drug Saf. 2022 Apr;31(4):467-475. doi: 10.1002/pds.5398. Epub 2021 Dec 23.
10
Association Between Preserved Ratio Impaired Spirometry and Clinical Outcomes in US Adults.美国成年人中,比值保留型肺通气功能障碍与临床结局的相关性。
JAMA. 2021 Dec 14;326(22):2287-2298. doi: 10.1001/jama.2021.20939.
美国慢性肾脏病患者贫血的患病率
PLoS One. 2014 Jan 2;9(1):e84943. doi: 10.1371/journal.pone.0084943. eCollection 2014.
4
Propensity score methods for confounding control in nonexperimental research.非实验性研究中用于控制混杂因素的倾向得分方法。
Circ Cardiovasc Qual Outcomes. 2013 Sep 1;6(5):604-11. doi: 10.1161/CIRCOUTCOMES.113.000359. Epub 2013 Sep 10.
5
Advances in CKD detection and determination of prognosis: executive summary of the National Kidney Foundation-Kidney Early Evaluation Program (KEEP) 2012 annual data report.慢性肾脏病检测及预后判定的进展:美国国家肾脏基金会-肾脏早期评估项目(KEEP)2012年度数据报告执行摘要
Am J Kidney Dis. 2013 Apr;61(4 Suppl 2):S1-3. doi: 10.1053/j.ajkd.2013.01.006.
6
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate.比较 CKD-EPI 方程和 MDRD 研究方程用于估计肾小球滤过率的风险预测。
JAMA. 2012 May 9;307(18):1941-51. doi: 10.1001/jama.2012.3954.
7
Sustainable community-based CKD screening methods employed by the National Kidney Foundation's Kidney Early Evaluation Program (KEEP).美国国家肾脏基金会的肾脏早期评估项目(KEEP)采用的基于社区的可持续慢性肾脏病筛查方法。
Am J Kidney Dis. 2011 Mar;57(3 Suppl 2):S4-8. doi: 10.1053/j.ajkd.2010.11.010.
8
Establishing a national chronic kidney disease surveillance system for the United States.建立美国国家慢性肾脏病监测系统。
Clin J Am Soc Nephrol. 2010 Jan;5(1):152-61. doi: 10.2215/CJN.05480809. Epub 2009 Dec 3.
9
A new equation to estimate glomerular filtration rate.一种估算肾小球滤过率的新公式。
Ann Intern Med. 2009 May 5;150(9):604-12. doi: 10.7326/0003-4819-150-9-200905050-00006.
10
CKD surveillance using laboratory data from the population-based National Health and Nutrition Examination Survey (NHANES).利用基于人群的国家健康和营养检查调查(NHANES)的实验室数据进行慢性肾脏病监测。
Am J Kidney Dis. 2009 Mar;53(3 Suppl 3):S46-55. doi: 10.1053/j.ajkd.2008.07.054.